142 related articles for article (PubMed ID: 29985729)
1. Platelet reactivity in overweight and obese patients undergoing cardiac surgery.
Ranucci M; Aloisio T; Dedda UD; La Rovere MT; De Arroyabe BML; Baryshnikova E
Platelets; 2019; 30(5):608-614. PubMed ID: 29985729
[TBL] [Abstract][Full Text] [Related]
2. Electric impedance platelet aggregometry in cardiac surgery patients: A comparative study of two technologies.
Ranucci M; Baryshnikova E; Crapelli GB; Ranucci M; Meloni S; Pistuddi V;
Platelets; 2016; 27(3):185-90. PubMed ID: 26270439
[TBL] [Abstract][Full Text] [Related]
3. The interaction between preoperative platelet count and function and its relationship with postoperative bleeding in cardiac surgery.
Ranucci M; Baryshnikova E
Platelets; 2017 Dec; 28(8):794-798. PubMed ID: 28277058
[TBL] [Abstract][Full Text] [Related]
4. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Transl Res; 2013 May; 161(5):421-9. PubMed ID: 23340049
[TBL] [Abstract][Full Text] [Related]
5. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery.
Ranucci M; Colella D; Baryshnikova E; Di Dedda U;
Br J Anaesth; 2014 Dec; 113(6):970-6. PubMed ID: 25209096
[TBL] [Abstract][Full Text] [Related]
6. Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel.
Puccini M; Rauch C; Jakobs K; Friebel J; Hassanein A; Landmesser U; Rauch U
Cardiovasc Drugs Ther; 2023 Aug; 37(4):833-837. PubMed ID: 35211819
[TBL] [Abstract][Full Text] [Related]
7. Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors.
Ranucci M; Aloisio T; Di Dedda U; Menicanti L; de Vincentiis C; Baryshnikova E;
PLoS One; 2019; 14(11):e0225771. PubMed ID: 31774869
[TBL] [Abstract][Full Text] [Related]
8. Comparison of factors affecting platelet reactivity in various platelet function tests.
Choi SY; Kim MH
Platelets; 2019; 30(5):631-636. PubMed ID: 30059640
[TBL] [Abstract][Full Text] [Related]
9. Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor.
Mingant F; Didier R; Gilard M; Martin F; Nicol PP; Ugo V; Lippert E; Galinat H
Platelets; 2018 May; 29(3):257-264. PubMed ID: 29580115
[TBL] [Abstract][Full Text] [Related]
10. Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort.
Bolliger D; Filipovic M; Matt P; Tanaka KA; Gregor M; Zenklusen U; Seeberger MD; Lurati Buse G
Platelets; 2016; 27(3):254-61. PubMed ID: 26367099
[TBL] [Abstract][Full Text] [Related]
11. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
Mahla E; Metzler H; Bornemann-Cimenti H; Prueller F; Raggam RB; Pregartner G; Berghold A; Baumann A; Goeroeg C; Gurbel PA
Thromb Haemost; 2018 May; 118(5):864-872. PubMed ID: 29625498
[TBL] [Abstract][Full Text] [Related]
12. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
[TBL] [Abstract][Full Text] [Related]
13. Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox?
Stamou SC; Nussbaum M; Stiegel RM; Reames MK; Skipper ER; Robicsek F; Lobdell KW
Ann Thorac Surg; 2011 Jan; 91(1):42-7. PubMed ID: 21172483
[TBL] [Abstract][Full Text] [Related]
14. Platelet-related cytokines among normal body mass index, overweight, and obese Malaysians.
Riyahi N; Tohit ERM; Thambiah SC; Ibrahim Z
Asia Pac J Clin Nutr; 2018; 27(1):182-188. PubMed ID: 29222897
[TBL] [Abstract][Full Text] [Related]
15. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
[TBL] [Abstract][Full Text] [Related]
16. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
Gremmel T; Koppensteiner R; Panzer S
PLoS One; 2015; 10(6):e0129666. PubMed ID: 26058047
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease.
Darlington A; Tello-Montoliu A; Rollini F; Ueno M; Ferreiro JL; Patel R; Desai B; Guzman LA; Bass TA; Angiolillo DJ
Thromb Haemost; 2014 Feb; 111(2):258-65. PubMed ID: 24154863
[TBL] [Abstract][Full Text] [Related]
19. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
20. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
